BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Bio NC

  Cell Microsystems Expands Availability of CellRaft Products and Technology

  Cell Microsystems announced today it is accelerating the development of new products based on its CellRaft Technology and expanding their availability in the marketplace.

  December 18, 2017

   · 

  3 min read
• Business

  Mass Innovation Labs Announces Expansion to NB Development Group’s Boston Landing

  Mass Innovation Labs will occupy 84,000 square feet of the 15-acre mixed-use development that is home to New Balance Athletics, Inc., among other world-class companies and organizations beginning in June of 2018.

  December 18, 2017

   · 

  5 min read
• Business

  McKesson Announces Departure of James Beer, EVP and CFO; Appoints Internal Successor, Britt Vitalone; Reaffirms Fiscal 2018 Outlook

  Britt Vitalone, senior vice president and chief financial officer, U.S. Pharmaceutical and McKesson Specialty Health, will be appointed executive vice president and chief financial officer of McKesson, effective January 1, 2018.

  December 18, 2017

   · 

  7 min read
• Drug Development

  Galera Therapeutics Reports Statistically Significant Results in a 223-Patient Phase 2b Trial of GC4419 for Severe Oral Mucositis in Patients with Head and Neck Cancer

  In the pre-specified secondary endpoints, GC4419 demonstrated a consistent effect across all efficacy measures.

  December 18, 2017

   · 

  4 min read
• Drug Development

  SciFluor Announces Positive Top-Line Results of Phase I/II Study of SF0166 Eye Drops to Treat Wet Age-Related Macular Degeneration

  SciFluor announced positive top-line results of a Phase 1/2 trial studying the treatment of ‘wet’ age-related macular degeneration (AMD) patients with SF0166, the company’s lead eye drop drug for back of the eye diseases.

  December 18, 2017

   · 

  6 min read
• 

  Business

  Intellia Therapeutics Gets New Chief

  Intellia has named John Leonard, M.D., President and CEO, effective January 1, 2018.

  December 18, 2017

   · 

  6 min read
• Generex Announces Investor Conference Call; Management to Provide Update on Initiatives & Strategic Plans

  The purpose of the conference call will be to provide investors with an update on the Company’s initiatives and strategic plans, including its capital reorganization, its controlling interest in Hema Diagnostic Systems,

  December 18, 2017

   · 

  2 min read
• Origin Agritech Announces Seed Product Pipeline and Biotechnology Trait Development Update

  Origin Agritech today released a progress update on growth platforms which are focused on the development and commercialization of superior corn seed products and high value biotechnology traits.

  December 18, 2017

   · 

  7 min read
• BioCapital

  GT Biopharma Files Application for NASDAQ Capital Market Listing

  GT Biopharma today announced that the Company has filed an application to list its common stock on the NASDAQ Capital Market.

  December 18, 2017

   · 

  3 min read
• Pharm Country

  Feinstein Institute Grant Funds Fertility Decision Tool for Women Cancer Patients

  Feinstein Institute for Medical Research Assistant Professor Catherine Benedict, PhD, has been awarded a two-year, $165,000 grant from the NIH to understand how young women who completed cancer treatment make fertility decisions and plan for future family-building.

  December 18, 2017

   · 

  4 min read